LUMONT 5 mg


Chewable tablet
scheduling status
S3
registration number
A 44/10.2.2/0824
What LUMONT 5 mg contains
Each tablet contains montelukast sodium, equivalent to 5 mg montelukast.
other ingredients
Mannitol, microcrystalline cellulose, ferric oxide red, croscarmellose sodium, hydroxypropyl cellulose, purified water, ethanol anhydrous, crospovidone, cherry dry flavour, aspartame, magnesium stearate.
Therapeutic classification
A.10.2.2 Other anti-asthmatics (Leukotriene receptor antagonist).
© 2026 SAHPRA. ALL RIGHTS RESERVED